Stem cells, cancer, and cancer stem cells.

PubWeight™: 50.27‹?› | Rank: Top 0.01% | All-Time Top 1000

🔗 View Article (PMID 11689955)

Published in Nature on November 01, 2001

Authors

T Reya1, S J Morrison, M F Clarke, I L Weissman

Author Affiliations

1: Departments of Pathology and Developmental Biology, Stanford University School of Medicine, Palo Alto, California 94305, USA. irv@stanford.edu

Associated clinical trials:

Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer | NCT00283075

Articles citing this

(truncated to the top 100)

Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17

The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89

Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions. Science (2015) 21.42

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77

Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature (2007) 19.33

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet (2008) 17.67

Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev (2006) 14.36

Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci U S A (2007) 13.58

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94

Clonal evolution in cancer. Nature (2012) 11.07

Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56

Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell (2008) 9.92

Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell (2002) 9.36

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer (2006) 8.50

Identification of cells initiating human melanomas. Nature (2008) 8.28

Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res (2006) 7.91

Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat Biotechnol (2011) 7.84

Pancreatic cancer. Annu Rev Pathol (2008) 6.96

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med (2014) 6.89

A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A (2004) 6.84

A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 6.35

Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A (2005) 6.32

A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell (2010) 6.00

Hypoxia-inducible factors, stem cells, and cancer. Cell (2007) 5.96

Molecular genetics of prostate cancer: new prospects for old challenges. Genes Dev (2010) 5.83

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell (2009) 5.81

Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med (2005) 5.68

Role of Notch signaling in cell-fate determination of human mammary stem/progenitor cells. Breast Cancer Res (2004) 5.60

Tumour heterogeneity and cancer cell plasticity. Nature (2013) 5.47

Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell (2012) 5.44

Characterization of clonogenic multiple myeloma cells. Blood (2003) 5.35

Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A (2004) 5.32

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells. Cell (2009) 5.30

TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer (2010) 5.27

Programmed cell death in animal development and disease. Cell (2011) 5.07

IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature (2010) 5.07

Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature (2010) 5.05

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature (2009) 4.99

AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res (2010) 4.89

Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell (2009) 4.82

CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells. Breast Cancer Res (2005) 4.79

Slug and Sox9 cooperatively determine the mammary stem cell state. Cell (2012) 4.77

Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev (2003) 4.71

IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest (2007) 4.71

Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell (2008) 4.68

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A (2006) 4.66

Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer (2009) 4.40

Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res (2009) 4.36

Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol (2006) 4.32

The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ (2008) 4.31

CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest (2010) 4.22

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways. Nat Rev Clin Oncol (2010) 4.22

Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell (2007) 4.21

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment. Proc Natl Acad Sci U S A (2009) 4.19

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov (2009) 4.12

The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci U S A (2005) 4.12

Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat Rev Cancer (2010) 4.10

PTEN-deficient intestinal stem cells initiate intestinal polyposis. Nat Genet (2007) 4.09

Normal and leukemic hematopoiesis: are leukemias a stem cell disorder or a reacquisition of stem cell characteristics? Proc Natl Acad Sci U S A (2003) 4.09

Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance. Proc Natl Acad Sci U S A (2007) 4.05

Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy. PLoS One (2008) 3.97

Epidermal stem cells of the skin. Annu Rev Cell Dev Biol (2006) 3.92

Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proc Natl Acad Sci U S A (2009) 3.87

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis. J Clin Oncol (2008) 3.84

Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell (2010) 3.82

Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med (2006) 3.81

Bmi1, stem cells, and senescence regulation. J Clin Invest (2004) 3.80

PML targeting eradicates quiescent leukaemia-initiating cells. Nature (2008) 3.75

Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell (2010) 3.70

Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci U S A (2004) 3.68

Imaging hematopoietic precursor division in real time. Cell Stem Cell (2007) 3.62

Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance. Cell Cycle (2009) 3.60

Genetic progression and the waiting time to cancer. PLoS Comput Biol (2007) 3.57

The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle (2009) 3.55

Prospective isolation of human clonogenic common myeloid progenitors. Proc Natl Acad Sci U S A (2002) 3.50

Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. Stem Cells (2007) 3.47

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts. Stem Cells (2010) 3.42

Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation. Cell Stem Cell (2010) 3.41

Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties. PLoS One (2008) 3.36

Asymmetric cell division: recent developments and their implications for tumour biology. Nat Rev Mol Cell Biol (2010) 3.28

Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics. Proc Natl Acad Sci U S A (2008) 3.26

The therapeutic promise of the cancer stem cell concept. J Clin Invest (2010) 3.26

Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia. JAMA (2010) 3.25

Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A (2007) 3.23

In vivo regeneration of murine prostate from dissociated cell populations of postnatal epithelia and urogenital sinus mesenchyme. Proc Natl Acad Sci U S A (2003) 3.19

Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet (2005) 3.11

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. Cancer Cell (2009) 3.11

Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA (2008) 3.03

Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis. J Cell Biol (2002) 2.96

The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. Proc Natl Acad Sci U S A (2006) 2.94

Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition. Cancer Res (2009) 2.93

Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. Blood (2005) 2.93

PTEN negatively regulates neural stem cell self-renewal by modulating G0-G1 cell cycle entry. Proc Natl Acad Sci U S A (2005) 2.93

miR-34 - a microRNA replacement therapy is headed to the clinic. Front Genet (2012) 2.89

Targeting HIF1α eliminates cancer stem cells in hematological malignancies. Cell Stem Cell (2011) 2.80

Paths to stemness: building the ultimate antitumour T cell. Nat Rev Cancer (2012) 2.79

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47. Sci Transl Med (2010) 2.79

Articles by these authors

A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature (2000) 16.75

Purification and characterization of mouse hematopoietic stem cells. Science (1988) 15.99

Epigenetic memory in induced pluripotent stem cells. Nature (2010) 14.31

Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell (1997) 12.60

Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94

Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med (2000) 11.35

Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A (2000) 10.88

The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity (1994) 9.50

The SCID-hu mouse: murine model for the analysis of human hematolymphoid differentiation and function. Science (1988) 9.05

A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (1983) 8.20

Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc Natl Acad Sci U S A (2001) 7.58

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1. Cell (1993) 7.10

Physiological migration of hematopoietic stem and progenitor cells. Science (2001) 7.02

Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus. Cell (1988) 7.01

The aging of hematopoietic stem cells. Nat Med (1996) 6.67

In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells. Proc Natl Acad Sci U S A (1999) 5.65

The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol (1995) 4.77

B220: a B cell-specific member of th T200 glycoprotein family. Nature (1981) 4.65

Flow cytometric identification of murine neutrophils and monocytes. J Immunol Methods (1996) 4.44

Infection of the SCID-hu mouse by HIV-1. Science (1988) 4.37

Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A (1992) 4.28

A developmental switch in thymic lymphocyte maturation potential occurs at the level of hematopoietic stem cells. Cell (1990) 4.23

The purification and characterization of fetal liver hematopoietic stem cells. Proc Natl Acad Sci U S A (1995) 4.21

bcl-2 inhibits apoptosis of neutrophils but not their engulfment by macrophages. J Exp Med (1994) 4.19

Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell (1997) 4.18

Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity (1997) 4.10

Identification of a murine Peyer's patch--specific lymphocyte homing receptor as an integrin molecule with an alpha chain homologous to human VLA-4 alpha. Cell (1989) 4.06

Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc Natl Acad Sci U S A (1992) 4.06

An immunoglobulin heavy-chain gene is formed by at least two recombinational events. Nature (1980) 3.99

Systemic overexpression of BCL-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood (1998) 3.98

Searching for hematopoietic stem cells: evidence that Thy-1.1lo Lin- Sca-1+ cells are the only stem cells in C57BL/Ka-Thy-1.1 bone marrow. J Exp Med (1992) 3.97

Thymus cell migration. Quantitative aspects of cellular traffic from the thymus to the periphery in mice. Eur J Immunol (1980) 3.84

Organ specificity of lymphocyte migration: mediation by highly selective lymphocyte interaction with organ-specific determinants on high endothelial venules. Eur J Immunol (1980) 3.80

Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilization. Proc Natl Acad Sci U S A (1997) 3.74

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation. Proc Natl Acad Sci U S A (2000) 3.68

Protochordate allorecognition is controlled by a MHC-like gene system. Nature (1982) 3.63

Thymus cell migration. J Exp Med (1967) 3.63

Enforced expression of Bcl-2 in monocytes rescues macrophages and partially reverses osteopetrosis in op/op mice. Cell (1997) 3.48

Isolation of two early B lymphocyte progenitors from mouse marrow: a committed pre-pre-B cell and a clonogenic Thy-1-lo hematopoietic stem cell. Cell (1986) 3.46

Transplanted human fetal neural stem cells survive, migrate, and differentiate in ischemic rat cerebral cortex. Proc Natl Acad Sci U S A (2004) 3.45

Mouse lymph node homing receptor cDNA clone encodes a glycoprotein revealing tandem interaction domains. Science (1989) 3.40

The murine T-cell receptor uses a limited repertoire of expressed V beta gene segments. Nature (1985) 3.36

Cell surface molecule associated with lymphocyte homing is a ubiquitinated branched-chain glycoprotein. Science (1986) 3.33

The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol (2000) 3.31

Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature (2000) 3.25

Evidence for a role of the integrin VLA-4 in lympho-hemopoiesis. J Exp Med (1991) 3.21

Bone marrow stromal cell lines with lymphopoietic activity express high levels of a pre-B neoplasia-associated molecule. Cell (1987) 3.15

Clonal analysis of hematopoietic stem-cell differentiation in vivo. Proc Natl Acad Sci U S A (1991) 3.14

A monoclonal antibody that recognizes B cells and B cell precursors in mice. J Exp Med (1981) 3.13

Cyclophosphamide/granulocyte colony-stimulating factor causes selective mobilization of bone marrow hematopoietic stem cells into the blood after M phase of the cell cycle. Blood (2001) 3.11

Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med (1991) 3.03

Cellular maturation of oncornavirus glycoproteins: topological arrangement of precursor and product forms in cellular membranes. Virology (1977) 3.01

Identification of a lineage of multipotent hematopoietic progenitors. Development (1997) 3.01

AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations. Proc Natl Acad Sci U S A (2001) 2.84

Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood (1997) 2.84

Down-regulation of homing receptors after T cell activation. J Immunol (1988) 2.80

Effects of substrate biodegradability on the mass and activity of the associated estuarine microbiota. Appl Environ Microbiol (1978) 2.78

In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A (2000) 2.76

Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood (2001) 2.75

Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol (1993) 2.73

Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity (1996) 2.71

Development of CD8alpha-positive dendritic cells from a common myeloid progenitor. Science (2000) 2.71

Lymphocyte homing receptors. Cell (1986) 2.70

The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med (2000) 2.67

A genetic analysis of neural progenitor differentiation. Neuron (2001) 2.66

From hematopoiesis to neuropoiesis: evidence of overlapping genetic programs. Proc Natl Acad Sci U S A (2001) 2.66

Lymphoid tissue architecture. Experimental analysis of the origin and distribution of T-cells and B-cells. Immunology (1972) 2.65

Prevention of programmed cell death in Caenorhabditis elegans by human bcl-2. Science (1992) 2.54

Lymphocyte adherence to high endothelial venules: characterization of a modified in vitro assay, and examination of the binding of syngeneic and allogeneic lymphocyte populations. J Immunol (1979) 2.42

Expression of MHC antigens by mouse thymic dendritic cells. J Immunol (1979) 2.39

Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev (1998) 2.37

Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species. Science (1986) 2.33

Differences in the migration of B and T lymphocytes: organ-selective localization in vivo and the role of lymphocyte-endothelial cell recognition. J Immunol (1982) 2.30

Early events in T-cell maturation. Annu Rev Immunol (1987) 2.27

Homing receptors and the control of lymphocyte migration. Immunol Rev (1986) 2.26

Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci U S A (1989) 2.24

Intrathymic maturation of murine T lymphocytes from CD8+ precursors. Proc Natl Acad Sci U S A (1989) 2.23

Structural characteristics of some murine RNA tumor viruses studied by lactoperoxidase iodination. Proc Natl Acad Sci U S A (1973) 2.18

Tissue reaction to three ceramics of porous and non-porous structures. J Biomed Mater Res (1972) 2.18

Blocking effect of lyt-2 antibodies on T cell functions. J Exp Med (1980) 2.15

Heritable germ and somatic cell lineage competitions in chimeric colonial protochordates. Proc Natl Acad Sci U S A (1999) 2.15

Cloning of a cDNA for a T cell-specific serine protease from a cytotoxic T lymphocyte. Science (1986) 2.13

Establishment of a normal hematopoietic and leukemia stem cell hierarchy. Cold Spring Harb Symp Quant Biol (2008) 2.13

AKR leukemogenesis: identification and biological significance of thymic lymphoma receptors for AKR retroviruses. Cell (1979) 2.10

Can stem cells cross lineage boundaries? Nat Med (2001) 2.08

Mouse hematopoietic stem cells. Blood (1991) 2.07

Thymus cell maturation. II. Differentiation of three "mature" subclasses in vivo. Cell Immunol (1975) 2.04

Peyer's patch-specific lymphocyte homing receptors consist of a VLA-4-like alpha chain associated with either of two integrin beta chains, one of which is novel. EMBO J (1989) 2.04

Direct fluorescent labeling of cells with fluorescein or rhodamine isothiocyanate. I. Technical aspects. J Immunol Methods (1980) 2.03

Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol (1993) 2.02

L-selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc Natl Acad Sci U S A (2001) 2.01

Antibodies to CD44 and integrin alpha4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment. Proc Natl Acad Sci U S A (1999) 1.98

Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci U S A (1998) 1.98

Thymus cell maturation. Studies on the origin of cortisone-resistant thymic lymphocytes. J Exp Med (1973) 1.96

Surface phenotype of Peyer's patch germinal center cells: implications for the role of germinal centers in B cell differentiation. J Immunol (1982) 1.95

Isolation of molecules recognized by monoclonal antibodies and antisera: the solid phase immunoisolation technique. Anal Biochem (1984) 1.91

Germinal centre B cells: antigen specificity and changes in heavy chain class expression. Nature (1982) 1.89